论文部分内容阅读
目的:探讨并观察合用稳心颗粒与胺碘酮治疗冠心病心律失常的临床效果。方法:从我院2013年05月至2016年01月收治的冠心病心律失常病患中选择82例,根据就诊顺序随机分作研究组与对照组,每组各41例。对照组常规应用胺碘酮治疗,研究组在其基础上加服稳心颗粒,并观察和比较两组患者的临床有效率及不良反应情况。结果:治疗4周后,研究组(92.7%)的临床有效率要显著地高于对照组(73.2%),组间对比存在显著差异,具有统计学意义(P<0.05)。研究组(4.9%)的不良反应发生率明显要低于对照组(22.0%),组间对比存在显著的差异性,具备统计学意义。结论:合用稳心颗粒与胺碘酮治疗冠心病心律失常的疗效佳,可有效缓解心律失常症状,且药物副作用轻微,值得推广应用。
Objective: To investigate and observe the clinical effect of combined Wenxin granules and amiodarone on arrhythmia of coronary heart disease. Methods: From our hospital from May 2013 to January 2016 admitted 82 cases of coronary heart disease patients, according to the order of treatment were randomly divided into study group and control group, 41 cases in each group. The control group routinely treated with amiodarone, the study group based on the addition of Wenxin particles, and to observe and compare the clinical efficacy and adverse reactions in both groups. Results: After 4 weeks of treatment, the clinical efficacy of the study group (92.7%) was significantly higher than that of the control group (73.2%). There was significant difference between the two groups (P <0.05). The incidence of adverse reactions in the study group (4.9%) was significantly lower than that in the control group (22.0%). There was significant difference between the two groups with statistical significance. Conclusion: The combination of Wenxin Granules and Amiodarone is effective in treating arrhythmia of coronary heart disease, which can effectively relieve the symptoms of arrhythmia, and the side effects of the medicament are minor, so it is worth popularizing and applying.